Literature DB >> 16675600

Angiotensin II upregulates toll-like receptor 4 on mesangial cells.

Gunter Wolf1, Jürgen Bohlender, Tzvetanka Bondeva, Thierry Roger, Friedrich Thaiss, Ulrich O Wenzel.   

Abstract

Angiotensin II (AngII) mediates proinflammatory properties by activating NF-kappaB transcription factor nuclear translocation and inducing the expression of chemokines. For examination of whether AngII modulates the expression of Toll-like receptor 4 (TLR4), a key element of the innate immune system that senses LPS, mouse mesangial cells (MMC) were treated with AngII. AngII upregulated TLR4 mRNA and protein in MMC, and this effect was mediated through AngII type 1 receptors. Reporter gene experiments indicate that an activating protein-1 (AP-1) as well as an E-26 specific sequence (Ets) binding site in the TLR4 promoter are responsible for the AngII-stimulated transcriptional activity of the TLR4 gene. Preincubation of MMC with AngII enhanced LPS-induced NF-kappaB activation and chemokine expression. Immunohistochemical analyses revealed that double-transgenic rats that overexpressed human renin and angiotensinogen expressed higher levels of glomerular TLR4 compared with normal Sprague-Dawley rats. In vivo, infusion with AngII but not with norepinephrine into rats for 7 d also enhanced glomerular NF-kappaB activation after systemic application of LPS, suggesting that the effects are independent of concomitantly induced hypertension. Together, these observations suggest that AngII leads to an activation of the innate immune system by a novel mechanism involving the upregulation of TLR4. Our data contribute to a better understanding of how exogenous infections may trigger renal autoimmune processes, particularly in pathophysiologic situations with high renal AngII concentrations. Because TLR4 binds endogenous ligands (e.g., extracellular matrix components) in addition to microbial products, AngII-mediated upregulation of TLR4 also could be relevant for the development of inflammation in many noninfectious renal diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675600     DOI: 10.1681/ASN.2005070699

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  34 in total

1.  Peptidomic Analysis of Urine from Youths with Early Type 1 Diabetes Reveals Novel Bioactivity of Uromodulin Peptides In Vitro.

Authors:  Julie A D Van; Sergi Clotet-Freixas; Joyce Zhou; Ihor Batruch; Chunxiang Sun; Michael Glogauer; Luca Rampoldi; Yesmino Elia; Farid H Mahmud; Etienne Sochett; Eleftherios P Diamandis; James W Scholey; Ana Konvalinka
Journal:  Mol Cell Proteomics       Date:  2019-12-26       Impact factor: 5.911

2.  Cyclic stretch enhances the expression of toll-like receptor 4 gene in cultured cardiomyocytes via p38 MAP kinase and NF-kappaB pathway.

Authors:  Kou-Gi Shyu; Bao-Wei Wang; Chiu-Mei Lin; Hang Chang
Journal:  J Biomed Sci       Date:  2010-03-05       Impact factor: 8.410

Review 3.  Toll-like Receptors in the Vascular System: Sensing the Dangers Within.

Authors:  Styliani Goulopoulou; Cameron G McCarthy; R Clinton Webb
Journal:  Pharmacol Rev       Date:  2016-01       Impact factor: 25.468

4.  Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells.

Authors:  Jun Wu; Xiao Yang; Yun-Fang Zhang; Ya-Ning Wang; Mei Liu; Xiu-Qing Dong; Jin-Jin Fan; Xue-Qing Yu
Journal:  Clin Vaccine Immunol       Date:  2010-03-03

5.  Angiotensin II facilitates fibrogenic effect of TGF-β1 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II.

Authors:  Yu-Sheng Li; Shu-Yuan Ni; Ying Meng; Xiao-Lan Shi; Xu-Wen Zhao; Hai-Hua Luo; Xu Li
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

Review 6.  Targeting toll-like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension?

Authors:  Kenia Pedrosa Nunes; Amanda Almeida de Oliveira; Francesca Elisabeth Mowry; Vinicia Campana Biancardi
Journal:  Br J Pharmacol       Date:  2018-08-09       Impact factor: 8.739

7.  A role for innate immunity in the development of hypertension.

Authors:  Jessica R Gomolak; Sean P Didion
Journal:  Med Hypotheses       Date:  2014-01-14       Impact factor: 1.538

8.  Angiotensin II upregulates Toll-like receptor 4 and enhances lipopolysaccharide-induced CD40 expression in rat peritoneal mesothelial cells.

Authors:  Jun Wu; Xiao Yang; Yun-Fang Zhang; Shu-Feng Zhou; Rui Zhang; Xiu-Qing Dong; Jin-Jin Fan; Mei Liu; Xue-Qing Yu
Journal:  Inflamm Res       Date:  2009-03-07       Impact factor: 4.575

9.  Stimulation of the Angiotensin II AT2 Receptor is Anti-inflammatory in Human Lipopolysaccharide-Activated Monocytic Cells.

Authors:  Mario Menk; Jan Adriaan Graw; Clarissa von Haefen; Marco Sifringer; David Schwaiberger; Thomas Unger; Ulrike Steckelings; Claudia D Spies
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 10.  Toll-like receptors, wound healing, and carcinogenesis.

Authors:  Johannes Kluwe; Ali Mencin; Robert F Schwabe
Journal:  J Mol Med (Berl)       Date:  2008-12-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.